Tōa hun-koah ko chè-liōng piàn-tiāu hòng-siā tī-liâu

Tuā hun-kuah ko tsè-liōng piàn-tiāu hòng-siā tī-liâu (Hypofractionated high-dose intensity-modulated radiotherapy; hàn-gí: 高劑量短程分次放射治療; ko tsè-liōng té-tîng hun-tshù hòng-siā tī-liâu) tse-sī tiâu-kiông hong-sia tī-liâu ê tsi̍t-tsióng si̍t-giām hîng-sik, kî-tiong khah-kuân ê X siā-suànn tsè-liōng iōng-teh khah-tsió ê hun-tshù (liâu-tîng), kiò-tsò Tuā hun-kuah hòng-siā tī-liâu. Sui-bóng ta̍k-pái hun-tshù ê tsè-liōng ko-î piau-tsún tī-liâu; m̄-ku tsóng tsè-liōng khah-ke.[1] Ǹg-bāng Tuā hun-kuah ê hong-sik kāng-khuán ū-hāu; m̄-ku ín-khí ê to̍k-sìng ē khah-sè.[1]

Liap-hōo-suànn gâm

2011-nî tsìn-hîng tsi̍t-hāng tsiam-tuì liap-hōo-suànn (prostate) gâm ê tshì-giām[2][1]. 2016-nî, HYPRO gián-kiù pò-kò teh 820 miâ tang-tiong huî-hiám kûn hi̍k-tsiá ko hong-hiám liap-hōo-suànn gâm ê huān-tsiá tang-tiong pí-kàu piau-tsún hun-kuah (39 pái 2 Gy hun-kuah, liân-suà 8 tsiu) hâm tuā hun-kuah (19 pái 3.4 Gy hun-kuah, liân-suà 6.5 tsiu) ê kiat-kó.[3]

Tsù-kái

Tsham-ua̍t

  • Radiation therapy
  • Dose fractionation
  • Prostate cancer

Guap-oo liân-kiat